Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration

Tinahones FJ., Coín Aragüez L., Murri M., Oliva Olivera W., Mayas Torres MD., Barbarroja N.

Prospective Study on Type 2 Diabetes, published in Diabetes Care (2013) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Diabetes Care (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23193206
PMCID
PMC3579349
DOI
10.2337/dc12-0194
Citations
60

Abstract (original English)

Objective Cell death determines the onset of obesity and associated insulin resistance. Here, we analyze the relationship among obesity, adipose tissue apoptosis, and insulin signaling. Research design and methods The expression levels of initiator (CASP8/9) and effector (CASP3/7) caspases as well as antiapoptotic B-cell lymphoma (BCL)2 and inflammatory markers were assessed in visceral (VAT) and subcutaneous (SAT) adipose tissue from patients with different degrees of obesity and without insulin resistance or diabetes. Adipose tissue explants from lean subjects were cultured with TNF-α or IL-6, and the expression of apoptotic and insulin signaling components was analyzed and compared with basal expression levels in morbidly obese subjects. Results SAT and VAT exhibited increased CASP3/7 and CASP8/9 expression levels and decreased BCL2 expression with BMI increase. These changes were accompanied by increased inflammatory cytokine mRNA levels and macrophage infiltration markers. In obese subjects, CASP3/7 activation and BCL2 downregulation correlated with the IRS-1/2-expression levels. Expression levels of caspases, BCL2, p21, p53, IRS-1/2, GLUT4, protein tyrosine phosphatase 1B, and leukocyte antigen-related phosphatase in TNF-α- or IL-6-treated explants from lean subjects were comparable with those found in adipose tissue samples from morbidly obese subjects. These insulin com

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueHumansInsulinTumor Necrosis Factor-alphaProto-Oncogene Proteins c-bcl-2Interleukin-6Signal TransductionSubcutaneous FatIntra-Abdominal FatGlucose Transporter Type 4

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research